SUPPLEMENT
Q1 2024 — Financial statement information
Q1 2024PDF · 16 pages312 KB
Three months ended March 31, 2024 2023 Net sales $ 8,003 $ 8,031 Operating expenses Cost of sales 4,329 4,613 Selling, general and administrative expenses 1,736 1,705 Research, development and related expenses 437 472 Total operating expenses 6,502 6,790 Operating income (loss) 1,501 1,241 Other expense (income), net 264 52 Income (loss) before income taxes 1,237 1,189 Provision (benefit) for income taxes 305 210 Income (loss) of consolidated group 932 979 Income (loss) from unconsolidated subsidiaries, net of taxes 1 2 Net income (loss) including noncontrolling interest 933 981 Less: Net income (loss) attributable to noncontrolling interest 5 5 Net income (loss) attributable to 3M $ 928 $ 976 Weighted average 3M common shares outstanding – basic 555.0 552.7 Earnings (loss) per share attributable to 3M common shareholders — basic $ 1.67 $ 1.77 Weighted average 3M common shares outstanding – diluted 555.9 553.2 Earnings (loss) per share attributable to 3M common shareholders — diluted $ 1.67 $ 1.76 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (LOSS) (Millions, except per-share amounts) (Unaudited) 1 -- 1 of 16 -- March 31, 2024 December 31, 2023 ASSETS Current assets Cash and cash equivalents $ 10,911 $ 5,933 Marketable securities – current 60 53 Accounts receivable – net 4,750 4,750 Inventories 4,897 4,822 Prepaids 655 485 Other current assets 340 336 Total current assets 21,613 16,379 Property, plant and equipment – net 9,072 9,159 Operating lease right of use assets 744 759 Goodwill and intangible assets – net 16,914 17,153 Other assets 6,900 7,130 Total assets $ 55,243 $ 50,580 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current portion of long-term debt $ 820 $ 2,947 Accounts payable 3,372 3,245 Accrued payroll 607 904 Accrued income taxes 383 365 Operating lease liabilities – current 227 225 Other current liabilities 7,747 7,611 Total current liabilities 13,156 15,297 Long-term debt 20,593 13,088 Other liabilities 16,561 17,327 Total liabilities 50,310 45,712 Total equity 4,933 4,868 Shares outstanding March 31, 2024: 553,361,257 December 31, 2023: 552,581,136 Total liabilities and equity $ 55,243 $ 50,580 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) 2 -- 2 of 16 -- Three months ended March 31, 2024 2023 NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 767 $ 1,275 Cash flows from investing activities: Purchases of property, plant and equipment (375) (475) Purchases and proceeds from sale or maturities of marketable securities and investments – net (11) 86 Other investing activities (7) 3 NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (393) (386) Cash flows from financing activities: Change in debt – net 5,509 (43) Purchases of treasury stock (21) (29) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 18 187 Dividends paid to shareholders (835) (827) Other financing activities (50) (4) NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 4,621 (716) Effect of exchange rate changes on cash and cash equivalents (17) (4) Net increase (decrease) in cash and cash equivalents 4,978 169 Cash and cash equivalents at beginning of year 5,933 3,655 Cash and cash equivalents at end of period $ 10,911 $ 3,824 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) 3 -- 3 of 16 -- Three months ended March 31, 2024 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales (1.5) % 0.9 % 3.3 % — % Acquisitions 0.6 0.1 0.1 0.4 Divestitures — (0.1) (0.3) (0.1) Translation 0.4 (4.3) 1.7 (0.6) Total sales change (0.5) % (3.4) % 4.8 % (0.3) % Three months ended March 31, 2024 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial (1.4) % — % — % (0.3) % (1.7) % Transportation and Electronics 2.7 1.4 — (1.5) 2.6 Health Care 1.0 — (0.3) (0.4) 0.3 Consumer (3.9) — — (0.4) (4.3) Total Company — 0.4 (0.1) (0.6) (0.3) 4Total sales change is calculated based on reported sales results. The components of sales change include organic local- currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post- transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum. 3M Company and Subsidiaries SALES CHANGE ANALYSIS4 (Unaudited) 4 -- 4 of 16 -- 3M discloses business segment operating income (loss) as its measure of segment profit/loss, reconciled to both total 3M operating income (loss) and income (loss) before taxes. Business segment operating income (loss) excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Unallocated”). Effective in the first quarter of 2024, 3M made certain changes within its business segments in its continuing effort to improve the alignment of businesses around markets and customers. The changes included the items described below. While they impacted the composition of certain divisions within 3M's business segments, they did not change the overall composition of segments or the measure of segment operating performance used by 3M’s chief operating decision maker (CODM). The financial information presented herein reflects the impact of these changes for all periods presented. Creation of Industrial Specialties division (within Safety and Industrial business segment) and Commercial Branding and Transportation division (within Transportation and Electronics business segment) 3M created the Industrial Specialties division within Safety and Industrial business segment, which consists of the former Closure and Masking Systems division along with certain products formerly within Industrial Adhesive and Tapes division and the Personal Safety division. Further, 3M created the Commercial Branding and Transportation division within the Transportation and Electronics business segment, which consists of the former Commercial Solutions division and the Transportation Safety division. Re-alignment from three to four divisions within Consumer business segment The Consumer business segment re-aligned from three divisions to the following four divisions: Consumer Safety and Well-Being, Home and Auto Care, Home Improvement, and Packaging and Expression. Division name changes within the Health Care business segment The names of three of the Heath Care segment's divisions were changed. The Medical Solutions, Oral Care, and Separation and Purification Sciences divisions were renamed to Medical Surgical (MedSurg), Dental Solutions, and Purification and Filtration, respectively. BUSINESS SEGMENT INFORMATION Three months ended March 31, NET SALES (Millions) 2024 2023 Safety and Industrial $ 2,732 $ 2,779 Transportation and Electronics 2,104 2,050 Health Care 2,017 2,010 Consumer 1,140 1,192 Corporate and Unallocated 10 — Total Company $ 8,003 $ 8,031 3M Company and Subsidiaries BUSINESS SEGMENTS (Unaudited) 5 -- 5 of 16 -- BUSINESS SEGMENT INFORMATION Three months ended March 31, OPERATING INCOME (LOSS) (Millions) 2024 2023 Safety and Industrial $ 657 $ 601 Transportation and Electronics 481 294 Health Care 354 360 Consumer 216 179 Total business segment operating income (loss) 1,708 1,434 Corporate and Unallocated Corporate special items: Net costs for significant litigation (63) (82) Divestiture costs (121) (102) Total corporate special items (184) (184) Other corporate (expense) income - net (23) (9) Total Corporate and Unallocated (207) (193) Total Company operating income (loss) 1,501 1,241 Other expense/(income), net 264 52 Income (loss) before income taxes $ 1,237 $ 1,189 Corporate and Unallocated Corporate and Unallocated operating income (loss) includes “corporate special items” and “other corporate expense-net”. Corporate special items include net costs for significant litigation impacting operating income (loss) associated with PFAS- related other environmental and Combat Arms Earplugs matters. In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023) costs associated with the Aearo portion of respirator mask/asbestos matters were also included in corporate special items. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were not included in the Corporate net costs for significant litigation special item, instead being reflected in the Safety and Industrial business segment. Corporate special items also include divestiture costs and divestiture-related restructuring costs impacting operating income. Divestiture costs include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. Other corporate expense-net includes certain enterprise and governance activities resulting in unallocated corporate costs and other activity and net costs that 3M may choose not to allocate directly to its business segments. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. 3M Company and Subsidiaries BUSINESS SEGMENTS - (CONTINUED) (Unaudited) 6 -- 6 of 16 -- In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies. Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable. This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include: GAAP amounts for which a measure adjusted for special items is also provided: Reasons 3M believes the measure is useful • Net sales (and sales change) Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items • Operating income (loss), segment operating income (loss) and operating income (loss) margin • Other expense (income), net • Income (loss) before taxes • Provision for income taxes and effective tax rate • Net income (loss) • Earnings (loss) per share Additional non-GAAP measures: • Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance • Adjusted EBITDA and adjusted EBITDA margin Considered in evaluating and managing operations; meaningful in analyses of ongoing underlying operating trends • Net debt Meaningful as indicator of liquidity and measure of capital structure strategy The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) 7 -- 7 of 16 -- Certain amounts adjusted for special items (non-GAAP measures): Three months ended March 31, 2023 (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Other expense (income), net Income (loss) before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) attributable to 3M Earnings per diluted share Safety and Industrial GAAP amounts $ 601 21.6 % Adjustments for special items: Net costs for significant litigation (39) Total special items (39) Adjusted amounts (non-GAAP measures)5 $ 562 20.2 % Transportation and Electronics GAAP amounts $ 2,050 $ 294 14.4 % Adjustments for special items: Manufactured PFAS products (345) (10) Total special items (345) (10) Adjusted amounts (non-GAAP measures)5 $ 1,705 $ 284 16.7 % Total Company GAAP amounts $ 8,031 $ 1,241 15.4 % $ 52 $ 1,189 $ 210 17.7 % $ 976 $ 1.76 Adjustments for special items: Net costs for significant litigation — 43 — 43 7 36 0.07 Manufactured PFAS products (345) (10) — (10) (3) (7) (0.01) Divestiture costs — 102 — 102 20 82 0.15 Total special items (345) 135 — 135 24 111 0.21 Adjusted amounts (non-GAAP measures)5 $ 7,686 $ 1,376 17.9 % $ 52 $ 1,324 $ 234 17.7 % $ 1,087 $ 1.97 Three months ended March 31, 2024 (Dollars in millions, except per share amounts) Net sales Sales change Operating income (loss) Operating income (loss) margin Other expense (income), net Income (loss) before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) attributable to 3M Earnings (loss) per diluted share Earnings (loss) per diluted share percent change Safety and Industrial GAAP amounts $ 657 24.1 % Adjustments for special items: Net costs for significant litigation 7 Total special items 7 Adjusted amounts (non-GAAP measures)5 $ 664 24.3 % Transportation and Electronics GAAP amounts $ 2,104 2.6 % $ 481 22.9 % Adjustments for special items: Manufactured PFAS products (281) (2) Total special items (281) (2) Adjusted amounts (non-GAAP measures)5 $ 1,823 6.9 % $ 479 26.3 % Total Company GAAP amounts $ 8,003 (0.3) % $ 1,501 18.8 % $ 264 $ 1,237 $ 305 24.7 % $ 928 $ 1.67 (5) % Adjustments for special items: Net costs for significant litigation — 70 (204) 274 31 243 0.44 Manufactured PFAS products (281) (2) — (2) (1) (1) — Divestiture costs — 121 (44) 165 8 157 0.28 Total special items (281) 189 (248) 437 38 399 0.72 Adjusted amounts (non-GAAP measures)5 $ 7,722 0.5 % $ 1,690 21.9 % $ 16 $ 1,674 $ 343 20.5 % $ 1,327 $ 2.39 21 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 8 -- 8 of 16 -- Year ended December 31, 2023 (Dollars in millions, except per share amounts) Net sales Sales change Income (loss) before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) attributable to 3M Earnings (loss) per diluted share Total Company GAAP amounts $ 32,681 (4.5) % $ (9,688) $ (2,691) 27.8 % $ (6,995) $ (12.63) Adjustments for special items: Net costs for significant litigation6 — 15,245 3,615 11,630 21.00 Manufactured PFAS products (1,289) 205 50 155 0.28 Gain on business divestitures — (36) (11) (25) (0.05) Russia exit charges (benefits) — (18) 3 (21) (0.04) Divestiture costs — 496 118 378 0.68 Total special items (1,289) 15,892 3,775 12,117 21.87 Adjusted amounts (non-GAAP measures)5 $ 31,392 (4.5) % $ 6,204 $ 1,084 17.5 % $ 5,122 $ 9.24 5These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion. 6For the per share amount, this includes adjusting-out the impact of this item causing weighted average shares outstanding to be the same for both basic and diluted loss per share in periods of resulting net losses. Year ended December 31, 2023 Sales Change4 Organic sales Acquisitions Divestitures Translation Total sales change Total Company (3.2) % 0.2 % (0.9) % (0.6) % (4.5) % Remove manufactured PFAS products special item impact — — (0.1) 0.1 — Adjusted total Company (non-GAAP measures)5 (3.2) % 0.2 % (1.0) % (0.5) % (4.5) % Three months ended March 31, 2024 Sales Change4 Organic sales Acquisitions Divestitures Translation Total sales change Total Company — % 0.4 % (0.1) % (0.6) % (0.3) % Remove manufactured PFAS products special item impact 0.8 — — — 0.8 Adjusted total Company (non-GAAP measures)5 0.8 % 0.4 % (0.1) % (0.6) % 0.5 % Transportation and Electronics 2.7 % 1.4 % — % (1.5) % 2.6 % Remove manufactured PFAS products special item impact 4.0 0.3 — — 4.3 Adjusted Transportation and Electronics (non-GAAP measures)5 6.7 % 1.7 % — % (1.5) % 6.9 % By Geographic Area Americas (1.5) % 0.6 % — % 0.4 % (0.5) % Remove manufactured PFAS products special item impact 0.6 — — — 0.6 Adjusted Americas (non-GAAP measures)5 (0.9) % 0.6 % — % 0.4 % 0.1 % Asia Pacific 0.9 % 0.1 % (0.1) % (4.3) % (3.4) % Remove manufactured PFAS products special item impact 1.7 — — — 1.7 Adjusted Asia Pacific (non-GAAP measures)5 2.6 % 0.1 % (0.1) % (4.3) % (1.7) % Europe, Middle East & Africa 3.3 % 0.1 % (0.3) % 1.7 % 4.8 % Remove manufactured PFAS products special item impact — — — — — Adjusted Europe, Middle East & Africa (non-GAAP measures)5 3.3 % 0.1 % (0.3) % 1.7 % 4.8 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 9 -- 9 of 16 -- Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non- GAAP measures): Three months ended March 31, Major GAAP Cash Flow Categories (dollars in millions) 2024 2023 Net cash provided by (used in) operating activities $ 767 $ 1,275 Net cash provided by (used in) investing activities (393) (386) Net cash provided by (used in) financing activities 4,621 (716) Three months ended March 31, Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2024 2023 Net cash provided by (used in) operating activities $ 767 $ 1,275 Adjustments for special items: Net costs for significant litigation after-tax payment impacts 351 58 Divestiture costs after-tax payment impacts 139 43 Divestiture-related restructuring after-tax payment impacts 1 2 Manufactured PFAS products impact after-tax payment impacts (70) 13 Total adjustments for special items 421 116 Adjusted net cash provided by (used in) operating activities (non-GAAP measure)7 $ 1,188 $ 1,391 Purchases of property, plant and equipment (PPE) (375) (475) Manufactured PFAS products impact - removing related purchases of PPE 20 30 Adjusted purchases of PPE (non-GAAP measure)7 $ (355) $ (445) Adjusted free cash flow (non-GAAP measure)7 $ 833 $ 946 Adjusted net income (loss) attributable to 3M (non-GAAP measure)5 $ 1,327 $ 1,087 Adjusted free cash flow conversion (non-GAAP measure)7 63 % 87 % 73M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the portion of payments of costs for significant litigation under the 2023 settlement agreements relative to Combat Arms Earplugs and relative to public water systems regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the pre-tax settlement payments). The impacts of certain tax-related divestiture costs are based on applicable tax rates and the timing of tax payments relative to underlying separation transactions. For other special items, the cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income (loss) attributable to 3M, adjusted for special items. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 10 -- 10 of 16 -- Adjusted EBITDA and adjusted EBITDA margin (non-GAAP measures): Adjusted EBITDA (non-GAAP measure)8 Adjusted EBITDA margin (non-GAAP measure)8 Three months ended March 31, Three months ended March 31, (Dollars in millions) 2024 2023 2024 2023 Safety and Industrial $ 799 $ 696 29.3 % 25.0 % Transportation and Electronics 562 361 30.8 % 21.2 % Health Care 504 510 25.0 % 25.3 % Consumer 254 217 22.3 % 18.2 % Corporate and Unallocated (23) 29 Total Company $ 2,096 $ 1,813 27.1 % 23.6 % Three months ended March 31, Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2024 2023 Adjusted net sales (non-GAAP measure)5 $ 7,722 $ 7,686 Net income (loss) attributable to 3M 928 976 Add/(subtract): Net income/(loss) attributable to noncontrolling interest 5 5 (Income)/loss from unconsolidated subsidiaries, net of taxes (1) (2) Provision for income taxes 305 210 Other expense/(income): Interest (Income)/expense 275 83 Pension & OPEB non-service cost (benefit) (11) (31) Depreciation and amortization (DA) expense 430 466 Adjustments for special items: Net costs for significant litigation 70 43 Manufactured PFAS products impact: Remove manufactured PFAS products operating (income) loss (2) (10) Subtract PFAS-related amount included in DA above (24) (29) Divestiture costs 121 102 Total special items 165 106 Adjusted EBITDA (non-GAAP measure)8 $ 2,096 $ 1,813 Adjusted EBITDA margin (non-GAAP measure)8 27.1 % 23.6 % 83M defines adjusted EBITDA as net income (loss) attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, 3M defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for special items that is then further adjusted for depreciation and amortization (DA) expense, net of the PFAS-related amount included in DA. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales, adjusted for special items. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 11 -- 11 of 16 -- Adjusted EBITDA (non-GAAP measure) Three months ended March 31, 2024 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Adjusted net sales (non-GAAP measure)5 $ 2,732 $ 1,823 $ 2,017 $ 1,140 $ 10 $ 7,722 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)5 $ 664 $ 479 $ 354 $ 216 $ (23) $ 1,690 Add/(subtract): Add depreciation and amortization (DA) expense 135 107 150 38 — 430 Subtract PFAS-related amount included in DA above — (24) — — — (24) Adjusted EBITDA (non-GAAP measure)8 $ 799 $ 562 $ 504 $ 254 $ (23) $ 2,096 Adjusted EBITDA margin (non-GAAP measure)8 29.3 % 30.8 % 25.0 % 22.3 % 27.1 % Adjusted EBITDA (non-GAAP measure) Three months ended March 31, 2023 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Adjusted net sales (non-GAAP measure)5 $ 2,779 $ 1,705 $ 2,010 $ 1,192 $ — $ 7,686 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)5 $ 562 $ 284 $ 360 $ 179 $ (9) $ 1,376 Add/(subtract): Add depreciation and amortization (DA) expense 134 106 150 38 38 466 Subtract PFAS-related amount included in DA above — (29) — — — (29) Adjusted EBITDA (non-GAAP measure)8 $ 696 $ 361 $ 510 $ 217 $ 29 $ 1,813 Adjusted EBITDA margin (non-GAAP measure)8 25.0 % 21.2 % 25.3 % 18.2 % 23.6 % Net debt (non-GAAP measure): Net Debt (non-GAAP measure) March 31, 2024 December 31, 2023 Total debt $ 21,413 $ 16,035 Less: Cash, cash equivalents and marketable securities 10,991 6,006 Net debt (non-GAAP measure)9 $ 10,422 $ 10,029 9The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 12 -- 12 of 16 -- Description of special items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities (including interest imputation on applicable settlement obligations), external legal fees, and insurance recoveries, along with the associated tax impacts. These costs also include the impact on the determination of earnings per diluted share of 3M’s option to satisfy a portion of amounts under the Combat Arms Earplugs settlement in shares. 3M does not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment. Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters are reflected as corporate special items in Corporate and Unallocated. In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023), costs associated with the Aearo portion of respirator mask/asbestos matters were reflected in corporate special items in Corporate and Unallocated. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were reflected as part of special items in the Safety and Industrial business segment. In the first quarter of 2024 and 2023, 3M made payments of approximately $371 million and $73 million, respectively, related to net costs for significant litigation. Divestiture costs: • These include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture, including net tax costs of entity structuring associated with the separation of Solventum. These also include interest expense on debt issued by Solventum for the period outstanding prior to the April 1, 2024 completion of the separation of Solventum from 3M. In the first quarter of 2024 and 2023, 3M made payments of approximately $134 million and $54 million, respectively, associated with divestiture costs. Divestiture-related restructuring actions: • In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In the first quarter of 2024 and 2023, 3M made payments of approximately $2 million and $3 million, respectively, associated with divestiture-related restructuring actions. Manufactured PFAS products: • These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non- service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated payments. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 13 -- 13 of 16 -- The spin-off of Solventum, the former 3M Health Care business, was completed on April 1, 2024. Beginning in the second quarter of 2024, Solventum's historical net income will be reported within 3M's financial statements as discontinued operations. However, 3M’s 2024 earnings outlook guidance reflects Solventum as discontinued operations for the full year, including the first quarter of 2024. Therefore, 3M is supplying the accompanying preliminary estimated information that is illustrative as if Solventum were reflected as a discontinued operation for certain historical periods. This financial information should be read together with the financial information included in 3M’s Current Report on Form 8-K filed April 4, 2024, and with the audited financial information (including the accompanying notes), Management Discussion and Analysis and other information included in 3M’s Annual Report on Form 10-K for the year ended December 31, 2023. The financial information that follows does not revise or otherwise amend or restate any previously filed financial information of 3M. This information is preliminary, unaudited, and based on current estimates, and remains subject to change. Reflecting Solventum income as discontinued operation 2024 forecast 2024 adjusted earnings per share (non-GAAP measure)5,10 $6.80 to $7.30 2024 adjusted other expense (income), net (non-GAAP measure)5,10 ~$75 to $100 million 2024 adjusted effective tax rate (non-GAAP measure)5,10 19% to 20% 103M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted outlook guidance it provides until close of a transaction. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - REFLECTING SOLVENTUM INCOME (LOSS) AS DISCONTINUED OPERATION (Unaudited) 14 -- 14 of 16 -- (Dollars in billions, except per share amounts) Net sales Sales change Operating income (loss) Operating income (loss) margin Other expense (income), net Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) from continuing operations per diluted share For the year ended December 31, 2022 As reported $ 34.2 Solventum discontinued operations (8.1) Revised - reflecting continuing operations $ 26.2 Adjustments for special items: Manufactured PFAS products (1.4) Continuing operations adjusted amounts (non-GAAP measures)5 $ 24.8 For the year ended December 31, 2023 As reported $ 32.7 (4.5) % $ (9.1) (27.9) % $ 0.6 $ (9.7) $ (2.7) 27.8 % $ (7.0) $ (12.63) Solventum discontinued operations (8.1) ~(1.5) to (1.6) — ~(1.5) to (1.6) ~(0.2) ~(1.3) to (1.4) ~(2.46) to (2.61) Revised - reflecting continuing operations $ 24.6 (5.9) % ~($10.6) to ($10.7) ~(43%) to (44%) ~0.6 ~($11.2) to ($11.3) ~($2.9) ~25.4 to 25.5% ~($8.3) to ($8.4) ~($15.09) to ($15.24) Adjustments for special items: Net costs for significant litigation — 14.87 (0.4) 15.25 3.62 11.63 21.00 Manufactured PFAS products (1.3) 0.21 — 0.21 0.05 0.16 0.28 Gain on business divestitures — (0.04) — (0.04) (0.01) (0.03) (0.05) Russia exit charges (benefits) — (0.02) — (0.02) 0.00 (0.02) (0.04) Divestiture costs — 0.01 — 0.01 0.00 0.01 0.02 Total special items (1.3) 15.0 (0.4) 15.4 3.7 11.7 21.21 Continuing operations adjusted amounts (non-GAAP measures)5 $ 23.3 (6.0) % ~$4.3 to $4.4 ~18.5% to 18.9% ~$0.2 ~$4.1 to $4.2 ~$0.8 ~19.1% to 19.3% ~$3.3 to $3.4 ~$5.97 to $6.12 Amounts may not foot or cross-foot due to rounding. (Dollars in billions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Other expense (income), net Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) from continuing operations per diluted share For the quarter ended March 31, 2023 As reported $ 8.0 $ 1.2 15.4 % $ 0.1 $ 1.2 $ 0.2 17.7 % $ 1.0 $ 1.76 Solventum discontinued operations (2.0) ~(0.4) — ~(0.4) ~(0.1) ~(0.3) ~(0.55) to (0.58) Revised - reflecting continuing operations $ 6.1 ~$0.9 ~14.1% to 14.5% $ 0.1 ~$0.8 ~$0.1 ~17.9% ~$0.7 ~$1.18 to $1.21 Adjustments for special items: Net costs for significant litigation — 0.04 — 0.04 0.01 0.04 0.07 Manufactured PFAS products (0.3) (0.01) — (0.01) — (0.01) (0.01) Divestiture costs — — — — — — — Total special items (0.3) 0.04 — 0.04 0.00 0.03 0.06 Continuing operations adjusted amounts (non-GAAP measures)5 $ 5.7 ~$0.9 ~15.6% to 16.0% ~$0.1 ~$0.8 to $0.9 ~$0.1 to 0.2 ~17.7% ~$0.7 ~$1.24 to $1.27 For the quarter ended March 31, 2024 As reported $ 8.0 $ 1.5 18.8 % $ 0.3 $ 1.2 $ 0.3 24.7 % $ 0.9 $ 1.67 Solventum discontinued operations (2.0) ~0.3 to 0.4 — ~(0.3) ~(0.1) ~(0.2) ~(0.38) to (0.42) Revised - reflecting continuing operations $ 6.0 ~$1.1 to $1.2 ~18.9% to 19.3% ~$0.2 ~$0.9 ~$0.2 ~23.7% ~$0.7 ~$1.25 to $1.29 Adjustments for special items: Net costs for significant litigation — 0.07 (0.20) 0.27 0.03 0.24 0.44 Manufactured PFAS products (0.3) — — — — — — Divestiture costs — 0.01 — 0.01 — — — Total special items (0.3) 0.07 (0.20) 0.28 0.03 0.25 0.44 Continuing operations adjusted amounts (non-GAAP measures)5 $ 5.7 ~$1.2 ~21.1% to 21.5% — ~$1.2 ~$0.2 to $0.3 ~20.9% ~$0.9 to $1.0 ~$1.69 to $1.73 Amounts may not foot or cross-foot due to rounding. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - REFLECTING SOLVENTUM NET INCOME AS DISCONTINUED OPERATION - (CONTINUED) (Unaudited) 15 -- 15 of 16 -- Full-Year 2024 Forecast Sales Change4 Organic sales Acquisitions Divestitures Translation Total sales change Total Company10 flat to +2% — % 0.75 % (1) % (0.25%) to +1.75% Remove manufactured PFAS products impact10 — % — % — % — % — % Adjusted total Company (non-GAAP measures)5,10 flat to +2% — % 0.75 % (1) % (0.25%) to +1.75% Year ended December 31, 2023 Sales Change4 Organic sales Acquisitions Divestitures Translation Total sales change Total Company10 (4.2) % 0.3 % (1.3) % (0.7) % (5.9) % Remove manufactured PFAS products impact10 (0.2) — — 0.1 (0.1) Adjusted total Company (non-GAAP measures)5,10 (4.4) % 0.3 % (1.3) % (0.6) % (6.0) % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES - REFLECTING SOLVENTUM NET INCOME AS DISCONTINUED OPERATION - (CONTINUED) (Unaudited) 16 -- 16 of 16 --